Olink Debuts Target 48 Immune Surveillance, Setting New Standards In Immune Biomarker Profiling
Portfolio Pulse from Benzinga Newsdesk
Olink has launched Target 48 Immune Surveillance, a new product aimed at setting new standards in immune biomarker profiling.
June 06, 2024 | 6:47 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Olink has introduced Target 48 Immune Surveillance, a new product designed to enhance immune biomarker profiling standards.
The launch of Target 48 Immune Surveillance is a significant product development for Olink, likely to positively impact its stock price in the short term due to the potential market interest and adoption in the biotech sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100